A8194-1

ABT-199

ABT-199, developed through a structure-based reverse engineering process, is a novel and specific inhibitor of B-cell lymphoma/leukemia 2 (BCL-2) maintaining a sub-nanomolar affinity towards BCL-2 and over three orders of magnitude less affinity towards BCL-XL

364.41 €

A8194-10

ABT-199

Apoptosis|Bcl-2 Family

368.65 €

A8194-100

ABT-199

Bcl-2 inhibitor,potent and selective

435.31 €

MBS9905624-INQUIRE

Cat Phosphorylated Tau 199 (PT-199) ELISA Kit

Ask for quotation

MBS9905625-INQUIRE

Cavy Phosphorylated Tau 199 (PT-199) ELISA Kit

Ask for quotation

MBS9905626-INQUIRE

Donkey Phosphorylated Tau 199 (PT-199) ELISA Kit

Ask for quotation